Syneron Medical (NSDQ:ELOS) remained in the red during its 3rd quarter, but managed to narrow its losses by 94.3% compared with the same period last year.
Wall Street Beat
Rochester Medical gains on exit from Foley Catheters business
Medical device maker Rochester Medical (NSDQ:ROCM) closed at a 1.2% increase yesterday after detailing its decision to exit the Foley Catheter business.
DJO Global narrows its Q3 losses
DJO Global made some progress during its 3rd quarter, reporting in the red but narrowing its losses by 12.4% along the way.
The San Diego, Calif.-based medical device company posted $22.6 million in net losses on sales of $274 million for the 3 months ended Sept. 29. That compared with a net loss of $25.8 million, on sales of $263 million during the same period last year.
iCad soars on Medicare reimbursement nod | Wall Street Beat
AtriCure’s Q3 misses expectations
Medtronic closes $816M buyout of China Kanghui Holdings
Cleveland HeartLab pulls in $15M | Wall Street Beat
Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.
The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic’s center for cardiovascular diagnostics and prevention.
Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.
Abiomed plunges 30% on federal investigation into Impella marketing
Robotics: Hansen gains 25% on $30M deal with Intuitive Surgical
Wall Street shuts down for 2nd day | Wall Street Beat
The New York Stock Exchange was closed for a 2nd day today for the 1st time in 124 years, after Hurricane Sandy had its way with lower Manhattan yesterday. The storm also took out the NASDAQ exchange.
The Category I hurricane killed at least 108 people as is raged up the Eastern Seaboard from the Caribbean, 39 of them in the U.S.
The NYSE and NASDAQ said they plan to re-open tomorrow.
A drab quarter for Cardinal Health’s medical device business
Cardinal Health (NYSE:CAH) reported disappointing numbers for its medical device business during the company’s 1st quarter, citing volume softness that led to a 6% dip in profit.
Medical device revenues amounted to just under $2.4 billion during the 3 months ended Sept. 30, 2012, representing a 1% increase year-over-year.